Same-day discharge after complex gynecologic oncology surgery is safe and feasible, with success tied to age, BMI, surgery ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights ...

An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves - insights ...

Early fallopian tube cell changes were found in a high‑risk patient. A live tissue bank and organoid system will help explore initial ovarian cancer development. Very little is currently understood ...

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.